A Wellington man is stoked to finally get his hands back on the weight loss drug he said changed his life. Wegovy was ...

Over 60 novel drug candidates are in late-stage clinical trials in China, and these will potentially compete directly with US ...

SINGAPORE - An injectable drug used to treat obesity is now available via prescription from any licensed physician in ...

The new arrangement could cut patients' copays to $25 per month, or less, for Wegovy, Zepbound, Ozempic and Rybelsus ...

Drugs aren’t the foundation of a healthy society. Your editorial raises a valid concern: equitable access to weight-loss drugs like Wegovy. However, while affordability matters, ...

Doctors explain why headaches are popular among Wegovy and Ozempic patients and how to treat and prevent them, including ...

The recent approval of weight-loss drug Wegovy in New Zealand has been hyped as a breakthrough in the country’s fight against ...

A little over a year after celebrating its 30th anniversary in China with a major production upgrade, Novo Nordisk is back ...

The Advertising Standards Authority (ASA) has banned nine rulings against ads for weight-loss jabs, including one featuring ...

Adverts for prescription -only weight-loss jabs have been banned by a watchdog. The Advertising Standards Authority (ASA) ruled against the ads, making it “crystal clear” that all injectable forms of ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay ...